The case for disease management in chronic kidney disease

Disease Management : DM
Randolph A ChenAllen R Nissenson

Abstract

Chronic kidney disease (CKD) is a growing epidemic in the United States and worldwide, with nearly two thirds of CKD patients also having diabetes, hypertension, or both. Morbidity and mortality among patients with CKD are high, as are the costs associated with care, which is highly fragmented. Disease management (DM) programs are designed to coordinate the delivery of care to patients, improve clinical outcomes, and reduce costs along the continuum of care. The goals of DM programs in CKD patients are to fill the gaps in current care by focusing on four key areas: (1) slowing the progression of CKD, (2) identifying and managing the complications of CKD, (3) identifying and managing associated comorbid conditions, and (4) smoothing the transition to renal replacement therapy (RRT). To be successful, this approach requires multidisciplinary collaboration among physicians (eg, primary care physicians, endocrinologists, cardiologists, nephrologists, surgeons) and participating caregivers including nurses, dieticians, social workers, and pharmacists. Patient identification, limited reimbursement, late patient referral, and lack of primary care physician and nephrologist knowledge about the importance and details of CKD management a...Continue Reading

Associated Clinical Trials

References

Mar 20, 1998·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·G T Obrador, B J Pereira
Aug 26, 1998·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·R J SchmidtG Hobbs
Aug 14, 1999·Journal of the American Society of Nephrology : JASN·G T ObradorB J Pereira
Mar 29, 2001·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·N W Levin, C Ronco
Apr 28, 2001·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·A R NissensonUNKNOWN Medical Advisory Board, RMS Disease Management, Inc
Jul 20, 2001·Journal of the American Society of Nephrology : JASN·Allen R NissensonEarl P Steinberg
Sep 5, 2001·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·B C AstorJ Coresh
Mar 5, 2002·Seminars in Dialysis·Shaan Anand, Allen R Nissenson
Mar 29, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Hariprasad S TrivediPaulette Saab
Apr 30, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Luis CarrerasMarta Carrera
Dec 25, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Josef CoreshAndrew S Levey
Jan 23, 2003·Journal of the American Society of Nephrology : JASN·Wolfgang C WinkelmayerJerry Avorn
Jan 29, 2003·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Austin G Stack
Aug 27, 2003·Journal of the American Society of Nephrology : JASN·Glenn M Chertow
Jan 9, 2004·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Robert FathiThomas H Marwick
Jun 18, 2004·Kidney International·Wendy L St PeterAllan J Collins
Aug 11, 2004·The American Journal of Medicine·Joshua J OfmanScott R Weingarten
Oct 19, 2004·Kidney & Blood Pressure Research·Donald S SilverbergDoron Schwartz
Dec 8, 2004·Journal of the American Society of Nephrology : JASN·Giuseppe RemuzziUNKNOWN RENAAL Study Group
Jan 14, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Teresa OrtegaJaime Alvarez-Grande
Apr 12, 2005·Advances in Chronic Kidney Disease·Samir ShahFarhad R Danesh
Aug 23, 2005·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Wolfgang C WinkelmayerDaniel H Solomon

❮ Previous
Next ❯

Citations

Jul 26, 2013·International Journal of Clinical Pharmacy·Salah M AbuRuzIzzat A Alawwa
Jan 22, 2008·Current Medical Research and Opinion·Matthew J TaylorDonald A Molony
Dec 7, 2013·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Chun-Mei LinJunne-Ming Sung
May 5, 2010·Advances in Chronic Kidney Disease·Vahakn B Shahinian, Rajiv Saran
Oct 24, 2007·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Bryan M CurtisAdeera Levin
Nov 28, 2012·Journal of Renal Care·Raquel C GreerL Ebony Boulware
Jun 10, 2015·Nature Reviews. Nephrology·Olivier J WoutersAndrew S Narva
Jul 1, 2011·Journal of Primary Care & Community Health·Suneetha MuthyalaByron Danielson
Nov 18, 2009·Laboratory Investigation; a Journal of Technical Methods and Pathology·Youli WangCharles W Heilig
Aug 19, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Amar A DesaiGlenn M Chertow
May 24, 2016·Medical Care·Maria A HanCarol M Mangione

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Advances in Chronic Kidney Disease
Anjay RastogiAllen R Nissenson
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Bryan M CurtisAdeera Levin
Journal of the American Society of Nephrology : JASN
Brenda R HemmelgarnBruce F Culleton
© 2022 Meta ULC. All rights reserved